Literature DB >> 27643903

Multiple Sclerosis.

Nicoline Schiess, Peter A Calabresi.   

Abstract

It is estimated that there are 300,000 people with multiple sclerosis (MS) in the United States and 2.3 million worldwide. Each MS attack can affect function in cognitive, emotional, motoric, sensory, or visual domains. Patients are often struck in the prime of their lives as they attempt to move forward with career, and family. Since the previous 2010 Seminars in Neurology Pearls and Pitfalls issue, the world of MS has drastically changed and advanced. Here the authors address the ever-changing MS world in both treatment options and diagnostics, covering easily missed differential diagnoses, newly available immunomodulatory therapy, and the challenges of safely treating patients. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2016        PMID: 27643903     DOI: 10.1055/s-0036-1585456

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  6 in total

Review 1.  Past, present and future role of retinal imaging in neurodegenerative disease.

Authors:  Amir H Kashani; Samuel Asanad; Jane W Chan; Maxwell B Singer; Jiong Zhang; Mona Sharifi; Maziyar M Khansari; Farzan Abdolahi; Yonggang Shi; Alessandro Biffi; Helena Chui; John M Ringman
Journal:  Prog Retin Eye Res       Date:  2021-01-15       Impact factor: 19.704

2.  Toxocara infection in the differential diagnosis of multiple sclerosis in the Middle East.

Authors:  Marwa Baalbaki; Mayssam El Najjar; Samir Atweh; Nabil K El Ayoubi
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-01-09

Review 3.  The Role of Cytotoxic T-Lymphocyte Antigen 4 in the Pathogenesis of Multiple Sclerosis.

Authors:  Maria Sofia Basile; Placido Bramanti; Emanuela Mazzon
Journal:  Genes (Basel)       Date:  2022-07-24       Impact factor: 4.141

Review 4.  Differential diagnosis of multiple sclerosis in Latin America.

Authors:  Y D Fragoso; F G Elso; A Carrá
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25

Review 5.  Outcome measures assisting treatment optimization in multiple sclerosis.

Authors:  Gabriel Pardo; Samantha Coates; Darin T Okuda
Journal:  J Neurol       Date:  2021-08-02       Impact factor: 4.849

6.  Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy.

Authors:  Paula Bachmann; Niklas Frahm; Jane Louisa Debus; Pegah Mashhadiakbar; Silvan Elias Langhorst; Barbara Streckenbach; Julia Baldt; Felicita Heidler; Michael Hecker; Uwe Klaus Zettl
Journal:  Pharmaceutics       Date:  2022-03-08       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.